The sound of silence: modulating anergy in T lymphocytes

Current Opinion in Immunology

Volumn 19, Issue 6, 2007, Pages 658-664

  Saibil, Samuel D ^a,b   Deenick, Elissa K ^a   Ohashi, Pamela S ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; DIACYLGLYCEROL; DIACYLGLYCEROL KINASE; GLYCOSPHINGOLIPID; LAT PROTEIN; LIGAND; RAS PROTEIN;

CELL CYCLE; CELL INTERACTION; CLONAL ANERGY; HUMAN; IN VIVO STUDY; INHIBITION KINETICS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD; CLONAL ANERGY; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DIACYLGLYCEROL KINASE; HUMANS; IMMUNE TOLERANCE; MEMBRANE PROTEINS; PROTEIN ISOFORMS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 36849015543     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2007.08.005     Document Type: Review

References (67)

1. Walker L.S., and Abbas A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2 (2002) 11-19
2. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
3. Lamb J.R., Skidmore B.J., Green N., Chiller J.M., and Feldmann M. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 157 (1983) 1434-1447
4. Nossal G.J.V. Cellular mechanisms of immunological tolerance. Annu Rev Immunol 1 (1983) 33-62
5. Jenkins M.K., and Schwartz R.H. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165 (1987) 302-319
6. Quill H., and Schwartz R.H. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J Immunol 138 (1987) 3704-3712
7. Bretscher P., and Cohn M. A theory of self-nonself discrimination. Science 169 (1970) 1042-1049
8. Schwartz R.H. Costimulation of T lymphocytes: The role of CD28, CTLA-4 and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71 (1992) 1065-1068
9. Vanier L.E., and Prud'homme G.J. Cyclosporin A markedly enhances superantigen-induced peripheral T cell deletion and inhibits anergy induction. J Exp Med 176 (1992) 37-46
10. Macian F., Garcia-Cozar F., Im S.H., Horton H.F., Byrne M.C., and Rao A. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109 (2002) 719-731
11. Heissmeyer V., Macian F., Im S.H., Varma R., Feske S., Venuprasad K., Gu H., Liu Y.C., Dustin M.L., and Rao A. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat Immunol 5 (2004) 255-265
12. Seroogy C.M., Soares L., Ranheim E.A., Su L., Holness C., Bloom D., and Fathman C.G. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. J Immunol 173 (2004) 79-85
13. Mackenzie D.A., Schartner J., Lin J., Timmel A., Jennens-Clough M., Fathman C.G., and Seroogy C.M. GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype. J Biol Chem 282 (2007) 9696-9702
14. Su L., Lineberry N., Huh Y., Soares L., and Fathman C.G. A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes. J Immunol 177 (2006) 7559-7566
15. Jeon M.-S., Atfield A., Venuprasad K., Krawczyk C., Sarao R., Elly C., Yang C., Arya S., Bachmaier K., Su L., et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21 (2004) 167-177
16. Berg-Brown N.N., Gronski M.A., Jones R.G., Elford A.R., Deenick E.K., Littman D.R., and Ohashi P.S. PKCθ signals activation versus tolerance in vivo. J Exp Med 199 (2004) 743-752
17. Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 6 (2006) 476-483
18. + T cells. Science 271 (1996) 1272-1276
19. + T cells. Science 271 (1996) 1276-1278
20. Zha Y., Marks R., Ho A.W., Peterson A.C., Janardhan S., Brown I., Praveen K., Stang S., Stone J.C., and Gajewski T.F. T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha. Nat Immunol 7 (2006) 1166-1173. This report and ref. [24] establish DGKs and DAG metabolism as key molecules in blocking Ras signaling and establishing anergy.
21. Marsland B.J., Nembrini C., Schmitz N., Abel B., Krautwald S., Bachmann M.F., and Kopf M. Innate signals compensate for the absence of PKC-{theta} during in vivo CD8(+) T cell effector and memory responses. Proc Natl Acad Sci U S A 102 (2005) 14374-14379
22. Zhong X.P., Hainey E.A., Olenchock B.A., Zhao H., Topham M.K., and Koretzky G.A. Regulation of T cell receptor-induced activation of the Ras-ERK pathway by diacylglycerol kinase zeta. J Biol Chem 277 (2002) 31089-31098
23. Sanjuan M.A., Jones D.R., Izquierdo M., and Merida I. Role of diacylglycerol kinase alpha in the attenuation of receptor signaling. J Cell Biol 153 (2001) 207-220
24. Olenchock B.A., Guo R., Carpenter J.H., Jordan M., Topham M.K., Koretzky G.A., and Zhong X.P. Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nat Immunol 7 (2006) 1174-1181. See annotation to ref. [20]
25. Smida M., Posevitz-Fejfar A., Horejsi V., Schraven B., and Lindquist J.A. A novel negative regulatory function of PAG: blocking Ras activation. Blood (2007). This report shows that PAG-Fyn complex can promote anergy in human T cells by blocking Ras activation independent of DGKs.
26. Davidson D., Schraven B., and Veillette A. PAG-associated FynT regulates calcium signaling and promotes anergy in T lymphocytes. Mol Cell Biol 27 (2007) 1960-1973
27. Kearney E.R., Pape K.A., Loh D.Y., and Jenkins M.K. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1 (1994) 327-339
28. Bachmaier K., Krawczyk C., Kozieradzki I., Kong Y.-Y., Sasaki T., Oliveira-dos-Santos A.J., Mariathasan S., Bouchard D., Wakeham A., Itie A., et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403 (2000) 211-216
29. Chiang Y.J., Kole H.K., Brown K., Naramura M., Fukuhara S., Hu R.-J., Jang I.K., Gutkind J.S., Shevach E., and Gu H. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403 (2000) 216-220
30. Safford M., Collins S., Lutz M.A., Allen A., Huang C.T., Kowalski J., Blackford A., Horton M.R., Drake C., Schwartz R.H., et al. Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol 6 (2005) 472-480
31. Schwartz R.H. T cell anergy. Annu Rev Immunol 21 (2003) 305-334
32. Rocha B., Tanchot C., and von Boehmer H. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J Exp Med 177 (1993) 1517-1521
33. Chiodetti L., Choi S., Barber D.L., and Schwartz R.H. Adaptive tolerance and clonal anergy are distinct biochemical states. J Immunol 176 (2006) 2279-2291. This study demonstrates the signaling differences between clonal anergy and adaptive tolerance.
34. Hundt M., Tabata H., Jeon M.S., Hayashi K., Tanaka Y., Krishna R., De Giorgio L., Liu Y.C., Fukata M., and Altman A. Impaired activation and localization of LAT in anergic T cells as a consequence of a selective palmitoylation defect. Immunity 24 (2006) 513-522. This study demonstrates that lipid modification of LAT, via palmitoylation, is important for the maintenance of the anergic state.
35. Fukata M., Fukata Y., Adesnik H., Nicoll R.A., and Bredt D.S. Identification of PSD-95 palmitoylating enzymes. Neuron 44 (2004) 987-996
36. Boussiotis V.A., Freeman G.J., Taylor P.A., Berezovskaya A., Grass I., Blazar B.R., and Nadler L.M. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat Med 6 (2000) 290-297
37. Wells A.D., Walsh M.C., Sankaran D., and Turka L.A. T cell effector function and anergy avoidance are quantitatively linked to cell division. J Immunol 165 (2000) 2432-2443
38. Rowell E.A., Walsh M.C., and Wells A.D. Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function. J Immunol 174 (2005) 3359-3368
39. Colombetti S., Benigni F., Basso V., and Mondino A. Clonal anergy is maintained independently of T cell proliferation. J Immunol 169 (2002) 6178-6186
40. Allen A., Zheng Y., Gardner L., Safford M., Horton M.R., and Powell J.D. The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction. J Immunol 172 (2004) 4797-4803
41. Kiyokawa H., Kineman R.D., Manova-Todorova K.O., Soares V.C., Hoffman E.S., Ono M., Khanam D., Hayday A.C., Frohman L.A., and Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85 (1996) 721-732
42. Li L., Iwamoto Y., Berezovskaya A., and Boussiotis V.A. A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nat Immunol 7 (2006) 1157-1165. Study shows that p27 is important in establishing anergy by allowing Smad3 transcriptional activity and not by blocking cell cycle entry.
43. Zheng Y., Collins S.L., Lutz M.A., Allen A.N., Kole T.P., Zarek P.E., and Powell J.D. A role for mammalian target of rapamycin in regulating T cell activation versus anergy. J Immunol 178 (2007) 2163-2170. This study demonstrates mTOR activation and not cell cycle progression is important in determining T cell activation versus anergy.
44. Parry R.V., Reif K., Smith G., Sanson D.M., Hemmings B.A., and Ward S.G. Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B. Eur J Immunol 27 (1997) 2495-2501
45. Song J., Salek-Ardakani S., Rogers P.R., Cheng M., van Parijs L., and Croft M. The costimulation-regulated duration of PKB activation controls T cell longevity. Nat Immunol (2004) 1-9
46. Shin I., Yakes F.M., Rojo F., Shin N.Y., Bakin A.V., Baselga J., and Arteaga C.L. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8 (2002) 1145-1152
47. Liang J., Zubovitz J., Petrocelli T., Kotchetkov R., Connor M.K., Han K., Lee J.H., Ciarallo S., Catzavelos C., Beniston R., et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8 (2002) 1153-1160
48. Inoki K., Li Y., Zhu T., Wu J., and Guan K.L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4 (2002) 648-657
49. Suzuki A., Yamaguchi M.T., Ohteki T., Sasaki T., Kaisho T., Kimura Y., Yoshida R., Wakeham A., Higuchi T., Fukumoto M., et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14 (2001) 523-534
50. Okazaki T., and Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 27 (2006) 195-201
51. Liang S.C., Latchman Y.E., Buhlmann J.E., Tomczak M.F., Horwitz B.H., Freeman G.J., and Sharpe A.H. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 33 (2003) 2706-2716
52. Yamazaki T., Akiba H., Iwai H., Matsuda H., Aoki M., Tanno Y., Shin T., Tsuchiya H., Pardoll D.M., Okumura K., et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 169 (2002) 5538-5545
53. Nishimura H., Nose M., Hiai H., Minator N., and Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11 (1999) 141-151
54. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., Sasayama S., Mizoguchi A., Hiai H., Minato N., et al. Autoimmune dilated cardiomyopathy in PD-1 receptor deficient mice. Science 291 (2001) 319-322
55. Probst H.C., McCoy K., Okazaki T., Honjo T., and van den Broek M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat Immunol 6 (2005) 280-286
56. Keir M.E., Liang S.C., Guleria I., Latchman Y.E., Qipo A., Albacker L.A., Koulmanda M., Freeman G.J., Sayegh M.H., and Sharpe A.H. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 203 (2006) 883-895. Refs. [56-59] establish tissue-resident PD-L1 signals important to the imposition and maintenance of the anergic state.
57. Martin-Orozco N., Wang Y.H., Yagita H., and Dong C. Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens. J Immunol 177 (2006) 8291-8295. See annotation to ref. [56].
58. Fife B.T., Guleria I., Gubbels B.M., Eagar T.N., Tang Q., Bour-Jordan H., Yagita H., Azuma M., Sayegh M.H., and Bluestone J.A. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med 203 (2006) 2737-2747. See annotation to ref. [56].
59. Tsushima F., Yao S., Shin T., Flies A., Flies S., Xu H., Tamada K., Pardoll D.M., and Chen L. Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy. Blood 110 (2007) 180-185. See annotation to ref. [56].
60. Butte M.J., Keir M.E., Phamduy T.B., Sharpe A.H., and Freeman G.J. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27 (2007) 111-122. Reference demonstrates that PD-L1 and B7-1 can ligate each other.
61. Parry R.V., Chemnitz J.M., Frauwirth K.A., Lanfranco A.R., Braunstein I., Kobayashi S.V., Linsley P.S., Thompson C.B., and Riley J.L. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 25 (2005) 9543-9553
62. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2 (2001) 261-268
63. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., and Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 (2006) 682-687
64. Trautmann L., Janbazian L., Chomont N., Said E.A., Gimmig S., Bessette B., Boulassel M.R., Delwart E., Sepulveda H., Balderas R.S., et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 12 (2006) 1198-1202
65. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., Mackey E.W., Miller J.D., Leslie A.J., DePierres C., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443 (2006) 350-354
66. Hickman S.P., Yang J., Thomas R.M., Wells A.D., and Turka L.A. Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells. J Immunol 177 (2006) 2186-2194
67. Knoechel B., Lohr J., Zhu S., Wong L., Hu D., Ausubel L., and Abbas A.K. Functional and molecular comparison of anergic and regulatory T lymphocytes. J Immunol 176 (2006) 6473-6483